Piper Jaffray Downgrades Cepheid on Lingering Manufacturing Issues
January 04, 2013
Piper Jaffray Downgrades Cepheid on Lingering Manufacturing Issues
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Cepheid Joins Attack on Roche PCR Patents with Lawsuit; Roche Expects Arbitration to Play Out
August 30, 2012 / PCR Insider - Spain's Stat-Diagnostica Aims to Market Near-patient IVD System in Europe, US in 2015
May 16, 2013 / PCR Insider - China's Zeesan Biotech Developing Portfolio of Melt Curve MDx Assays after SFDA Approves TB Tests
April 25, 2013 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Cowen & Co. Initiates Coverage of GenMark, Nanosphere with Outperform Ratings
April 22, 2013 / GenomeWeb Daily News